Cargando…

Growth-inhibitory and cell cycle-arresting properties of the rice bran constituent tricin in human-derived breast cancer cells in vitro and in nude mice in vivo

Tricin, a flavone found in rice bran, inhibits the growth of human-derived malignant MDA-MB-468 breast tumour cells at submicromolar concentrations. As part of the exploration of tricin as a potential cancer chemopreventive agent, we investigated the duration and cell cycle specificity of growth inh...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, H, Hudson, E A, Mann, P, Verschoyle, R D, Greaves, P, Manson, M M, Steward, W P, Gescher, A J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410014/
https://www.ncbi.nlm.nih.gov/pubmed/15316567
http://dx.doi.org/10.1038/sj.bjc.6602124
_version_ 1782155918018871296
author Cai, H
Hudson, E A
Mann, P
Verschoyle, R D
Greaves, P
Manson, M M
Steward, W P
Gescher, A J
author_facet Cai, H
Hudson, E A
Mann, P
Verschoyle, R D
Greaves, P
Manson, M M
Steward, W P
Gescher, A J
author_sort Cai, H
collection PubMed
description Tricin, a flavone found in rice bran, inhibits the growth of human-derived malignant MDA-MB-468 breast tumour cells at submicromolar concentrations. As part of the exploration of tricin as a potential cancer chemopreventive agent, we investigated the duration and cell cycle specificity of growth inhibition elicited by tricin in vitro and the effect of tricin on the development of MDA-MB-468 tumours grown in immune-compromised MF-1 mice in vivo. Preincubation of MDA-MB-468 cells with tricin (1–40 μM) for 72 h compromised cell growth after tricin removal, and such irreversibility was not observed in human breast-derived nonmalignant HBL-100 cells. Tricin (⩾5 μM) arrested MDA-MB-468 cells in the G2/M phase of the cell cycle without inducing apoptosis as adjudged by annexin V staining. In nude mice consumption of tricin with the diet (0.2%, w w(−1)) from 1 week prior to MDA-MB-468 cell implantation failed to impede tumour development. Steady-state levels of tricin in plasma, breast tumour tissue and intestinal mucosa, as measured by HPLC, were 0.13 μM and 0.11 and 63 nmol g(−1), respectively. Cells were exposed to tricin (0.11, 1.1 or 11 μM) in vitro for 72 h and then implanted into mice. The volume of tumours in animals bearing cells pre-exposed to 11 μM tricin was less than a third of that in mice with control cells, while tumours from cells incubated with 0.1 or 1.1 μM tricin were indistinguishable from controls. These results suggest that the potent breast tumour cell growth-inhibitory activity of tricin in vitro does not directly translate into activity in the nude mouse bearing the MDA MB-468 tumour. While the results do not support the notion that tricin is a promising candidate for breast cancer chemoprevention, its high levels in the gastrointestinal tract after dietary intake render exploration of its ability to prevent colorectal carcinogenesis propitious.
format Text
id pubmed-2410014
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-24100142009-09-10 Growth-inhibitory and cell cycle-arresting properties of the rice bran constituent tricin in human-derived breast cancer cells in vitro and in nude mice in vivo Cai, H Hudson, E A Mann, P Verschoyle, R D Greaves, P Manson, M M Steward, W P Gescher, A J Br J Cancer Experimental Therapeutics Tricin, a flavone found in rice bran, inhibits the growth of human-derived malignant MDA-MB-468 breast tumour cells at submicromolar concentrations. As part of the exploration of tricin as a potential cancer chemopreventive agent, we investigated the duration and cell cycle specificity of growth inhibition elicited by tricin in vitro and the effect of tricin on the development of MDA-MB-468 tumours grown in immune-compromised MF-1 mice in vivo. Preincubation of MDA-MB-468 cells with tricin (1–40 μM) for 72 h compromised cell growth after tricin removal, and such irreversibility was not observed in human breast-derived nonmalignant HBL-100 cells. Tricin (⩾5 μM) arrested MDA-MB-468 cells in the G2/M phase of the cell cycle without inducing apoptosis as adjudged by annexin V staining. In nude mice consumption of tricin with the diet (0.2%, w w(−1)) from 1 week prior to MDA-MB-468 cell implantation failed to impede tumour development. Steady-state levels of tricin in plasma, breast tumour tissue and intestinal mucosa, as measured by HPLC, were 0.13 μM and 0.11 and 63 nmol g(−1), respectively. Cells were exposed to tricin (0.11, 1.1 or 11 μM) in vitro for 72 h and then implanted into mice. The volume of tumours in animals bearing cells pre-exposed to 11 μM tricin was less than a third of that in mice with control cells, while tumours from cells incubated with 0.1 or 1.1 μM tricin were indistinguishable from controls. These results suggest that the potent breast tumour cell growth-inhibitory activity of tricin in vitro does not directly translate into activity in the nude mouse bearing the MDA MB-468 tumour. While the results do not support the notion that tricin is a promising candidate for breast cancer chemoprevention, its high levels in the gastrointestinal tract after dietary intake render exploration of its ability to prevent colorectal carcinogenesis propitious. Nature Publishing Group 2004-10-04 2004-08-17 /pmc/articles/PMC2410014/ /pubmed/15316567 http://dx.doi.org/10.1038/sj.bjc.6602124 Text en Copyright © 2004 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Experimental Therapeutics
Cai, H
Hudson, E A
Mann, P
Verschoyle, R D
Greaves, P
Manson, M M
Steward, W P
Gescher, A J
Growth-inhibitory and cell cycle-arresting properties of the rice bran constituent tricin in human-derived breast cancer cells in vitro and in nude mice in vivo
title Growth-inhibitory and cell cycle-arresting properties of the rice bran constituent tricin in human-derived breast cancer cells in vitro and in nude mice in vivo
title_full Growth-inhibitory and cell cycle-arresting properties of the rice bran constituent tricin in human-derived breast cancer cells in vitro and in nude mice in vivo
title_fullStr Growth-inhibitory and cell cycle-arresting properties of the rice bran constituent tricin in human-derived breast cancer cells in vitro and in nude mice in vivo
title_full_unstemmed Growth-inhibitory and cell cycle-arresting properties of the rice bran constituent tricin in human-derived breast cancer cells in vitro and in nude mice in vivo
title_short Growth-inhibitory and cell cycle-arresting properties of the rice bran constituent tricin in human-derived breast cancer cells in vitro and in nude mice in vivo
title_sort growth-inhibitory and cell cycle-arresting properties of the rice bran constituent tricin in human-derived breast cancer cells in vitro and in nude mice in vivo
topic Experimental Therapeutics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410014/
https://www.ncbi.nlm.nih.gov/pubmed/15316567
http://dx.doi.org/10.1038/sj.bjc.6602124
work_keys_str_mv AT caih growthinhibitoryandcellcyclearrestingpropertiesofthericebranconstituenttricininhumanderivedbreastcancercellsinvitroandinnudemiceinvivo
AT hudsonea growthinhibitoryandcellcyclearrestingpropertiesofthericebranconstituenttricininhumanderivedbreastcancercellsinvitroandinnudemiceinvivo
AT mannp growthinhibitoryandcellcyclearrestingpropertiesofthericebranconstituenttricininhumanderivedbreastcancercellsinvitroandinnudemiceinvivo
AT verschoylerd growthinhibitoryandcellcyclearrestingpropertiesofthericebranconstituenttricininhumanderivedbreastcancercellsinvitroandinnudemiceinvivo
AT greavesp growthinhibitoryandcellcyclearrestingpropertiesofthericebranconstituenttricininhumanderivedbreastcancercellsinvitroandinnudemiceinvivo
AT mansonmm growthinhibitoryandcellcyclearrestingpropertiesofthericebranconstituenttricininhumanderivedbreastcancercellsinvitroandinnudemiceinvivo
AT stewardwp growthinhibitoryandcellcyclearrestingpropertiesofthericebranconstituenttricininhumanderivedbreastcancercellsinvitroandinnudemiceinvivo
AT gescheraj growthinhibitoryandcellcyclearrestingpropertiesofthericebranconstituenttricininhumanderivedbreastcancercellsinvitroandinnudemiceinvivo